Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis

Emilia AnderssonDepartment Oncology-Pathology; Karolinska Institutet; Karolinska University Hospital; Stockholm, Sweden

Isabel PoschkeDepartment Oncology-Pathology; Karolinska Institutet; Karolinska University Hospital; Stockholm, Sweden;Division of Molecular Oncology of Gastrointestinal Tumors; German Cancer Research Center; Heidelberg, Germany

Lisa VillabonaDepartment Oncology-Pathology; Karolinska Institutet; Karolinska University Hospital; Stockholm, Sweden

Joseph W CarlsonDepartment Oncology-Pathology; Karolinska Institutet; Karolinska University Hospital; Stockholm, Sweden

Andreas LundqvistDepartment Oncology-Pathology; Karolinska Institutet; Karolinska University Hospital; Stockholm, Sweden

Rolf KiesslingDepartment Oncology-Pathology; Karolinska Institutet; Karolinska University Hospital; Stockholm, Sweden

Barbara SeligerInstitute of Medical Immunology; Martin Luther University Halle-Wittenberg; Halle/Saale, Germany

Giuseppe V MasucciDepartment Oncology-Pathology; Karolinska Institutet; Karolinska University Hospital; Stockholm, SwedenCorrespondence[email protected]

show all

Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis

KONI_A_1052213_supplementary_material.zip

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis

KONI_A_1052213_supplementary_material.zip

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date